Get the Stockscreener App
48.32
4.27%
1.98
Twist Bioscience Corp stock is traded at $48.32, with a volume of 686.88K.
It is up +4.27% in the last 24 hours and up +19.01% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$46.34
Open:
$46.96
24h Volume:
686.88K
Relative Volume:
0.91
Market Cap:
$2.80B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-13.06
EPS:
-3.7
Net Cash Flow:
$-95.52M
1W Performance:
+17.54%
1M Performance:
+19.01%
6M Performance:
+14.42%
1Y Performance:
+100.75%
1-Day Range:
$46.93
$49.13
1-Week Range:
$39.81
$49.13
52-Week Range:
$23.07
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
48.32 | 2.80B | 277.49M | -192.14M | -95.52M | -3.70 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience's chief accounting officer sells shares worth $34,870 - Investing.com
Twist Bioscience named a Best Idea for 2025 at TD Cowen - Yahoo Finance
Twist Bioscience shares hold Buy rating, price target on solid guidance - Investing.com
Twist Bioscience's SWOT analysis: DNA storage innovation propels stock outlook - Investing.com
Leerink Partnrs Issues Positive Forecast for TWST Earnings - Defense World
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Twist Bioscience Co. (NASDAQ:TWST) Receives $51.22 Average Target Price from Brokerages - Defense World
Q1 EPS Forecast for Twist Bioscience Increased by Analyst - MarketBeat
What is William Blair’s Forecast for TWST FY2026 Earnings? - Defense World
Cathie Wood's ARK makes major plays in Recursion, Twist Bioscience stock - Investing.com Canada
FY2026 Earnings Estimate for TWST Issued By William Blair - MarketBeat
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Victory Capital Management Inc. - MarketBeat
Twist Bioscience price target lowered to $52 from $55 at Barclays - Yahoo Finance
Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey
Barclays Cuts Twist Bioscience (NASDAQ:TWST) Price Target to $52.00 - MarketBeat
Twist Bioscience (NASDAQ:TWST) Price Target Raised to $54.00 at Scotiabank - MarketBeat
Robert W. Baird Forecasts Strong Price Appreciation for Twist Bioscience (NASDAQ:TWST) Stock - MarketBeat
Strong FY24 performance prompts target hike for Twist Bioscience shares - Investing.com
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Call Transcript - Insider Monkey
Thrivent Financial for Lutherans Makes New $43.99 Million Investment in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp (TWST) Shares Up 12.31% on Nov 19 - GuruFocus.com
Twist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Principal Financial Group Inc. - MarketBeat
Earnings call: Twist Bioscience reports robust Q4 with revenue up 27% - Investing.com
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: R - GuruFocus.com
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Twist Bioscience: Fiscal Q4 Earnings Snapshot - The Washington Post
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps - Yahoo Finance
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Corp Q4 FY24 Earnings: EPS of -$0.59, Revenue S - GuruFocus.com
Twist Bioscience earnings beat by $0.12, revenue topped estimates - Investing.com
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results - Yahoo Finance
Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: Wh - GuruFocus.com
Twist Bioscience Earnings Preview - Benzinga
DNA Synthesis Market Analysis and Forecast, 2024-2028 - GlobeNewswire Inc.
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Sells 301,765 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp (TWST) Trading Down 3.52% on Nov 14 - GuruFocus.com
Twist Bioscience director Robert Chess sells $170,138 in stock By Investing.com - Investing.com Australia
Twist Bioscience CEO Emily Leproust sells $382,448 in stock By Investing.com - Investing.com Australia
Twist Bioscience's chief legal officer sells $72,332 in stock By Investing.com - Investing.com Australia
Twist Bioscience director Robert Chess sells $170,138 in stock - Investing.com India
Twist Bioscience SVP Paula Green sells $64,653 in stock By Investing.com - Investing.com Australia
Twist Bioscience SVP Paula Green sells $64,653 in stock - Investing.com India
Creative Planning Has $210,000 Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Co. (NASDAQ:TWST) COO Sells $278,259.40 in Stock - MarketBeat
Robert F. Werner Sells 1,448 Shares of Twist Bioscience Co. (NASDAQ:TWST) Stock - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) CFO Sells $185,536.00 in Stock - MarketBeat
Twist Bioscience CEO Emily Leproust sells $639,368 in stock - Investing.com India
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):